title: Could nitazoxanide be added to other essential medicines for integrated neglected tropical disease control and elimination?
authors.affiliation: Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America; James A. Baker III Institute for Public Policy, Rice University, Houston, Texas, United States of America.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Hotez
mesh_terms: D000977:Antiparasitic Agents / Q000627:therapeutic use*; D003140:Communicable Disease Control / Q000379:methods*; D060740:Disease Eradication / Q000379:methods; D006801:Humans; D058069:Neglected Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D009574:Nitro Compounds; D010272:Parasitic Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D013844:Thiazoles / Q000627:therapeutic use*; D014329:Tropical Climate
chemical_list: D000977:Antiparasitic Agents; D009574:Nitro Compounds; D013844:Thiazoles; C041747:nitazoxanide